BCM
AGN.PRA

BlueCrest Capital Management’s Allergan plc AGN.PRA Stock Holding History

BlueCrest Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-21,614
Closed -$17.8M – 991
2016
Q3 		$17.8M Sell
21,614
-5,004,386
-100% -$4.33B 0.56% 16
2016
Q2 		$4.18M Buy
5,026,000
+5,010,409
+32,137% +$4.18B 0.17% 134
2016
Q1 		$14.3M Buy
15,591
+2,189
+16% +$2.09M 0.89% 10
2015
Q4 		$13.8M Buy
+13,402
New +$13.5M 0.57% 16

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlueCrest Capital Management's AGN.PRA Position: Q4 2016 in Review

BlueCrest Capital Management sold out of Allergan plc (AGN.PRA) in Q4 2016, closing a stake of 21,614 shares — an estimated $17.8M sold.

BlueCrest Capital Management first reported a position in AGN.PRA in Q4 2015 and held it in 4 quarters. The position peaked at $17.8M in Q3 2016. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

  • BlueCrest Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • BlueCrest Capital Management sold 21,614 Allergan plc shares in Q4 2016, an estimated $17.8M.
  • BlueCrest Capital Management first reported a position in Allergan plc in Q4 2015 and held it in 4 quarters.
  • BlueCrest Capital Management's Allergan plc position peaked at $17.8M in Q3 2016.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlueCrest Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.